Global Regulatory Intelligence
Log in |  Register

Login to your account

Username *
Password *
Remember Me

Create an account

Registering to our Regulatory Updates easy andis should only
take few minutes. To begin, enter your email enter your email
address below so we can check to see if it is already existing
in our records. Your email address will also be used as your
user name when you log in.

Fields marked with an asterisk (*) are required.
Name *
Username *
Password *
Verify password *
Email *
Verify email *
Captcha *
Reload Captcha
   

USA: FDA Draft and Final Guidance’s Detail Development of New Drugs for Neurological Disorders

Friday, February 16, 2018: The US Food and Drug Administration (FDA) released seven draft, revised draft and final guidance documents on everything from how to develop new drugs to treat early Alzheimer’s, Duchenne Muscular Dystrophy and acute migraines to guidance on how to prepare a pre-request for designation for a combination product.

FDA Commissioner noted the five guidance’s issued to address neurological disorders "benefited from the streamlined approach" of a pilot project testing "a new, streamlined process for writing science-based, practical guidance documents and getting them out more quickly."

 
 
 
 
 
 
More Details
© 2016 MakroCare. All Rights Reserved.
  Privacy policy